Your Current Position:  NEWS > Industry Series
  • 【Industry Series】 China Strengthens Position as Global Peptide Manufacturing Hub
    2026-03-25
    Recent investments in GMP-compliant facilities and quality management systems have enabled Chinese manufacturers to meet stringent international regulatory requirements, including US FDA and EMA standards. The trend is expected to accelerate as multinational pharmaceutical companies seek reliable, high-quality supply chain partners.
TOP
+86 147 3718 6312
8614737186312